| Robust enumeration of cell subsets from tissue expression profiles AM Newman, CL Liu, MR Green, AJ Gentles, W Feng, Y Xu, CD Hoang, ... Nature methods 12 (5), 453-457, 2015 | 12425 | 2015 |
| Determining cell type abundance and expression from bulk tissues with digital cytometry AM Newman, CB Steen, CL Liu, AJ Gentles, AA Chaudhuri, F Scherer, ... Nature biotechnology 37 (7), 773-782, 2019 | 4151 | 2019 |
| The prognostic landscape of genes and infiltrating immune cells across human cancers AJ Gentles, AM Newman, CL Liu, SV Bratman, W Feng, D Kim, VS Nair, ... Nature medicine 21 (8), 938-945, 2015 | 3362 | 2015 |
| Association of reactive oxygen species levels and radioresistance in cancer stem cells M Diehn, RW Cho, NA Lobo, T Kalisky, MJ Dorie, AN Kulp, D Qian, ... nature 458 (7239), 780-783, 2009 | 3072 | 2009 |
| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ... Nature medicine 20 (5), 548-554, 2014 | 2583 | 2014 |
| Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Y Shimono, M Zabala, RW Cho, N Lobo, P Dalerba, D Qian, M Diehn, ... cell 138 (3), 592-603, 2009 | 1479 | 2009 |
| Integrated digital error suppression for improved detection of circulating tumor DNA AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ... Nature biotechnology 34 (5), 547-555, 2016 | 1321 | 2016 |
| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 1184 | 2020 |
| Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review JD Merker, GR Oxnard, C Compton, M Diehn, P Hurley, AJ Lazar, ... Archives of pathology & laboratory medicine 142 (10), 1242-1253, 2018 | 1177 | 2018 |
| Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... Cancer discovery 7 (12), 1394-1403, 2017 | 1063 | 2017 |
| Individuality and variation in gene expression patterns in human blood AR Whitney, M Diehn, SJ Popper, AA Alizadeh, JC Boldrick, DA Relman, ... Proceedings of the National Academy of Sciences 100 (4), 1896-1901, 2003 | 952 | 2003 |
| Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells KS Chan, I Espinosa, M Chao, D Wong, L Ailles, M Diehn, H Gill, ... Proceedings of the National Academy of Sciences 106 (33), 14016-14021, 2009 | 811 | 2009 |
| Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 699 | 2020 |
| Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ... Nature communications 7 (1), 11815, 2016 | 691 | 2016 |
| Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme Y Liang, M Diehn, N Watson, AW Bollen, KD Aldape, MK Nicholas, ... Proceedings of the National Academy of Sciences 102 (16), 5814-5819, 2005 | 674 | 2005 |
| ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group J Pascual, G Attard, FC Bidard, G Curigliano, L de Mattos-Arruda, ... Annals of Oncology 33 (8), 750-768, 2022 | 645 | 2022 |
| Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer C Rolfo, P Mack, GV Scagliotti, C Aggarwal, ME Arcila, F Barlesi, T Bivona, ... Journal of Thoracic Oncology 16 (10), 1647-1662, 2021 | 642 | 2021 |
| Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers CM Blakely, TBK Watkins, W Wu, B Gini, JJ Chabon, CE McCoach, ... Nature genetics 49 (12), 1693-1704, 2017 | 582 | 2017 |
| Identification of noninvasive imaging surrogates for brain tumor gene-expression modules M Diehn, C Nardini, DS Wang, S McGovern, M Jayaraman, Y Liang, ... Proceedings of the National Academy of Sciences 105 (13), 5213-5218, 2008 | 565 | 2008 |
| Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma DM Kurtz, F Scherer, MC Jin, J Soo, AFM Craig, MS Esfahani, JJ Chabon, ... Journal of Clinical Oncology 36 (28), 2845-2853, 2018 | 541 | 2018 |
Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of MedicineVerified email at stanford.edu
